
    
      Prospective, multi-center, single-arm, two-phase clinical study. This study will be conducted
      in two phases.

      The first phase will consist of ten (10) subjects enrolled and treated using the SoundBite
      Crossing System with 30 day follow-up. An analysis shall be performed after 10 subjects
      undergo treatment with the SoundBite Crossing System and complete 30 day follow-up. This
      analysis shall be utilized to provide insight into product performance and safety.

      The second phase will consist of up to forty (40) subjects enrolled and treated using the
      SoundBite Crossing System with 30 day follow-up. An analysis will be generated on this
      subject cohort after 30 day follow-up is complete.
    
  